Price: 29.51

Today's Change: -0.21

Today's Percent Change: 3.90%

Today's Volume: 1009557

Average Daily Volume: 2781070

52 week low: 16.08

52 week high: 29.92

Market cap: 7080000000.0

EBITDA: 1180000000.0

EBITDA / market_cap: 16.67%

Earnings per Share (EPS): 1.76

EPS / price: 5.96%

Dividend Yield: 1.73%

Dividend per share: 0.5

Book value: 6.99

Price to Book Ratio: 4.25

Price to Earnings (P/E) Ratio: 16.73

Price to Earnings Growth (PEG) Ratio: 1.78

Price to Sales (P/S) Ratio: 0.72

Short Ratio: 2.35

Exchange: "NYQ"

Short term: UP (Previous: DOWN)

Mid term: UP (Previous: DOWN)

Long term: UP (Previous: DOWN)

Support: 25.63

Resistance: 25.95

Pivot point: 25.81

SMA 10: 25.17

SMA 50: 23.90

SMA 100: 22.18

RSI 10: 63.03

RSI 50: 59.76

RSI 100: 58.79

EMA 10: 25.09

EMA 50: 23.59

EMA 100: 21.61

STRONG BUY

Based on 12 buy signals and 0 sell signals

Previous signal: strong buy

19.79

NEGATIVE

HUN
HUN

@FlyOnTheWallHQ: Lifeline_Life Clips $LCLP Shares Rise As They Prepare For New Institutional Investment Within 30 Days Experts agre… https://t.co/YjHi0IZKlc

@FlyOnTheWallHQ: RT @StockWatchHQ: Gilead Sciences $GILD CEO To Confirm Amgen $AMGN Acquisition Discussions Happening In Foster City https://t.co/PNKET4QvUU…

@StockWatchHQ: RT @StockWatchHQ: Gilead Sciences $GILD CEO To Confirm Amgen $AMGN Acquisition Discussions Happening In Foster City https://t.co/PNKET4QvUU…

@ThisLincolnian: Scott J. Wright Purchases 4,950 Shares of Huntsman Co. $HUN Stock https://t.co/u9b4s3xwj6

@StockWatchHQ: Gilead Sciences $GILD CEO To Confirm Amgen $AMGN Acquisition Discussions Happening In Foster City… https://t.co/kH0Nz3I5vl

@WatchlistN: Huntsman Co. $HUN Given Average Rating of “Hold” by Analysts https://t.co/bCTiRGPICh